Novozymes 1H 2023 Roadshow Investor Presentation

Novozymes' first-half 2023 roadshow presentation covering financial results, business segment performance, and 2023 guidance. The company reported 3% organic sales growth supported by strong pricing and highlighted continued momentum in bioenergy, while Food, Beverages & Human Health faced destocking headwinds. Presentation includes outlook, equity story, ESG metrics, and divisional performance across Consumer Biosolutions and Agriculture & Industrial Biosolutions.